These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21562972)

  • 81. Short-term preseasonal immunotherapy: is early clinical efficacy related to the basophil response?
    Kepil Özdemir S; Sin BA; Güloğlu D; İkincioğulları A; Gençtürk Z; Mısırlıgil Z
    Int Arch Allergy Immunol; 2014; 164(3):237-45. PubMed ID: 25170594
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis.
    Pauli G; Larsen TH; Rak S; Horak F; Pastorello E; Valenta R; Purohit A; Arvidsson M; Kavina A; Schroeder JW; Mothes N; Spitzauer S; Montagut A; Galvain S; Melac M; André C; Poulsen LK; Malling HJ
    J Allergy Clin Immunol; 2008 Nov; 122(5):951-60. PubMed ID: 19000581
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Oral allergy syndrome in patients with airborne pollen allergy treated with specific immunotherapy.
    Czarnecka-Operacz M; Jenerowicz D; Silny W
    Acta Dermatovenerol Croat; 2008; 16(1):19-24. PubMed ID: 18358104
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Intralymphatic allergen-specific immunotherapy: an effective and safe alternative treatment route for pollen-induced allergic rhinitis.
    Hylander T; Latif L; Petersson-Westin U; Cardell LO
    J Allergy Clin Immunol; 2013 Feb; 131(2):412-20. PubMed ID: 23374268
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Characterization of oral immune cells in birch pollen-allergic patients: impact of the oral allergy syndrome and sublingual allergen immunotherapy on antigen-presenting cells.
    Mascarell L; Rak S; Worm M; Melac M; Soulie S; Lescaille G; Lemoine F; Jospin F; Paul S; Caplier L; Hasséus B; Björhn C; Zeldin RK; Baron-Bodo V; Moingeon P
    Allergy; 2015 Apr; 70(4):408-19. PubMed ID: 25631199
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis.
    Wahn U; Tabar A; Kuna P; Halken S; Montagut A; de Beaumont O; Le Gall M;
    J Allergy Clin Immunol; 2009 Jan; 123(1):160-166.e3. PubMed ID: 19046761
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study.
    Serrano P; Justicia JL; Sánchez C; Cimarra M; Fernández-Távora L; Orovitg A; Moreno C; Guerra F; Alvà V
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):247-52. PubMed ID: 19354072
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Vaccination for birch pollen allergy: comparison of the affinities of specific immunoglobulins E, G1 and G4 measured by surface plasmon resonance.
    Jakobsen CG; Bodtger U; Poulsen LK; Roggen EL
    Clin Exp Allergy; 2005 Feb; 35(2):193-8. PubMed ID: 15725191
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Phl p 1-specific human monoclonal IgE and design of a hypoallergenic group 1 grass pollen allergen fragment.
    Levin M; Rydnert F; Källström E; Tan LW; Wormald PJ; Lindstedt M; Greiff L; Ohlin M
    J Immunol; 2013 Jul; 191(2):551-60. PubMed ID: 23761636
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Preventive Administration of Non-Allergenic Bet v 1 Peptides Reduces Allergic Sensitization to Major Birch Pollen Allergen, Bet v 1.
    Akinfenwa O; Huang HJ; Linhart B; Focke-Tejkl M; Vrtala S; Poroshina A; Nikonova A; Khaitov M; Campion NJ; Eckl-Dorna J; Niederberger-Leppin V; Kratzer B; Tauber PA; Pickl WF; Kundi M; Campana R; Valenta R
    Front Immunol; 2021; 12():744544. PubMed ID: 34795666
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Epicutaneous immunotherapy with a hypoallergenic Bet v 1 suppresses allergic asthma in a murine model.
    Siebeneicher S; Reuter S; Wangorsch A; Krause M; Foetisch K; Heinz A; Naito S; Reuter A; Taube C; Vieths S; Scheurer S; Toda M
    Allergy; 2015 Dec; 70(12):1559-68. PubMed ID: 26304061
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Allergens. Heterogeneity of molecular sensitization profiles in grass pollen allergy--implications for immunotherapy?
    Darsow U; Brockow K; Pfab F; Jakob T; Petersson CJ; Borres MP; Ring J; Behrendt H; Huss-Marp J
    Clin Exp Allergy; 2014; 44(5):778-86. PubMed ID: 24598010
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Allergen-related approaches to immunotherapy.
    Rolland JM; Gardner LM; O'Hehir RE
    Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Molecular profiles of IgE to Phleum pratense in children with grass pollen allergy: implications for specific immunotherapy.
    Tripodi S; Frediani T; Lucarelli S; Macrì F; Pingitore G; Di Rienzo Businco A; Dondi A; Pansa P; Ragusa G; Asero R; Faggian D; Plebani M; Matricardi PM
    J Allergy Clin Immunol; 2012 Mar; 129(3):834-839.e8. PubMed ID: 22206774
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Continuous apple consumption induces oral tolerance in birch-pollen-associated apple allergy.
    Kopac P; Rudin M; Gentinetta T; Gerber R; Pichler Ch; Hausmann O; Schnyder B; Pichler WJ
    Allergy; 2012 Feb; 67(2):280-5. PubMed ID: 22070352
    [TBL] [Abstract][Full Text] [Related]  

  • 96. High-dose sublingual immunotherapy in children at 8-year follow-up.
    Leonardi S; Spicuzza L; La Rosa M
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):259-60. PubMed ID: 19354077
    [No Abstract]   [Full Text] [Related]  

  • 97. [Immunotherapy for allergic rhinitis induced by Japanese cedar pollens].
    Ohashi Y
    Arerugi; 2008 May; 57(5):519-23. PubMed ID: 18520172
    [No Abstract]   [Full Text] [Related]  

  • 98. An epicutaneous therapeutic pollen-allergen extract delivery system in an allergic rhinitis mouse model: based on allergen loading on DC-specific aptamers conjugated nanogolds.
    Pordel S; Haghnavaz N; Rezaee M; Shobeiri SS; Ansari B; Dashti M; Moghadam M; Khorrami M; Sankian M
    Immunol Res; 2024 Jun; 72(3):460-475. PubMed ID: 38091227
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Recombinant allergens for allergen-specific immunotherapy: 10 years anniversary of immunotherapy with recombinant allergens.
    Valenta R; Linhart B; Swoboda I; Niederberger V
    Allergy; 2011 Jun; 66(6):775-83. PubMed ID: 21352238
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Reduction in allergen-specific IgE binding as measured by microarray: A possible surrogate marker for effects of specific immunotherapy.
    Wollmann E; Lupinek C; Kundi M; Selb R; Niederberger V; Valenta R
    J Allergy Clin Immunol; 2015 Sep; 136(3):806-809.e7. PubMed ID: 25913196
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.